The vaccine-induced rally continues - Tuesday Review, November 24

By: Miguel A. Rodriguez

13:52, 25 November 2020

The global markets rebound as Biden’s transition lifts investors hope

The US

The progress reported by the pharma companies to deliver a COVID-19 vaccine caused the benchmarks to close in the green. The fact that Trump finally agreed with the transition of power at the White House added momentum. USA30 went up 1.54%, reaching its highest level since March. USA500 added 1.62%, while TECH100 inched up 1.31%.

Crude Oil closed 1.5% higher at $43.69 a barrel.

Gold settled at $1,804.60 per ounce after it lost 1.8%.

The Dollar Index traded at 92.235.


Asia and Australia

The benchmarks edged higher as President-elect Joe Biden received the formal go-ahead to begin his transition to the White House. Gains in the energy, real estate, and financial sectors contributed to the surge.

Japan225 surged 2.5%, reaching its highest level since May 1991.

HongKong45 went up 0.6%.

Down under, Australia200 closed 1.26% higher.



The markets ended higher as they are enthusiastic about the progress towards a viable COVID-19 vaccine. Also, one of the largest European economies posted a GDP rebound in Q3. Germany30 and UK100 each traded 0.6% higher. France40 rose 0.9%.

Brent Oil gained 1.1% to $46.57 per barrel.

EUR/USD closed at 1.1877 after it went up 0.3%.


Share this article

This information/research prepared by Miguel A. Rodriguez does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. The research analyst primarily responsible for the content of this research report, in part or in whole, certifies that the views about the companies and their securities expressed in this report accurately reflect his/her personal views and consequently any person acting on it does so entirely at their own risk.The research provided does not constitute the views of KW Investments Ltd nor is it an invitation to invest with KW Investments Ltd. The research analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.The research analyst in not employed by KW Investments Ltd. You are encouraged to seek advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit that conforms to your specific investment objectives, financial situation, or particular financial needs before making a commitment to invest. The laws of the Republic of Seychelles shall govern any claim relating to or arising from the contents of the information/ research provided.